
Sarah Hancox
@sarahhhancox
Doctor | Imperial graduate | Gastroenterology trainee in Yorkshire | Travel, scuba, netball
ID: 532228170
21-03-2012 11:20:51
381 Tweet
130 Followers
243 Following











π As use of subcutaneous infliximab in IBD gathers pace, what do we know about the immune response of patients treated with SC vs IV IFX? Sarah Hancox, Francesco Morda, Chris Black and Christian Selinger show that the risk of antidrug antibody formation is similar in SC vs IV

This is really important! Previous studies showed v low rates of ADA when switching from IV to SC IFX. It was selection bias - those pts were already established on IFX & declared themselves as not being ADA formers. Sarah Hancox shows we still need IMM for new SC IFX.




Casual climb up Castle Hill this morning #thighburn #thisisqueensland Townsville Townsville North Queensland



Come face to face with breathtaking mega marine life at the SS Yongala wreck! Thanks to Adrenalin Dive for sharing! #townsvilleshines
